COURTNEY WILLIAMS: Open Payments
NPI 1275074908 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,498 in 81 payments from 17 companies in 2025. Trend: 2023 $740 · 2024 $1,184 · 2025 $1,498
Food & beverage: $1,498
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 22 | $378 |
| ABBVIE INC. | 20 | $261 |
| Janssen Pharmaceuticals, Inc | 8 | $201 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $153 |
| Vanda Pharmaceuticals Inc. | 5 | $130 |
| Otsuka America Pharmaceutical, Inc. | 4 | $94 |
| Neurocrine BioSciences, Inc. | 2 | $52 |
| Collegium Pharmaceutical, Inc. | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Tris Pharma Inc | 1 | $23 |
Products named: COBENFY, VRAYLAR, SPRAVATO, CAPLYTA, FANAPT, REXULTI, INGREZZA, Jornay PM.
Industry payments across VA — which companies pay providers there.
